Compare
Medtronic vs Tandem Diabetes Care (MDT vs TNDM)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Medtronic (MDT) returned +12.6% and Tandem Diabetes Care (TNDM) +15.3%; so far this year the figures are +6.0% and -23.1%.
Medtronic is the larger company by market value, about 110.4 times the size of Tandem Diabetes Care.
Revenue grew +9.8% at MDT and +6.8% at TNDM over the last year.
MDT yields 2.81%. TNDM pays no dividend.
Data as of the latest close. Not investment advice.
Relative performance
| MDT | TNDM | |
|---|---|---|
| Price | $101.80 | $16.91 |
| 1-day | -2.90% | -6.00% |
| YTD | +5.98% | -23.07% |
| 1 year | +12.61% | +15.27% |
| 3 years | +43.68% | -4.73% |
| Market cap | $130.2B | $1.2B |
| P/E | 25.0 | — |
| P/S | 3.47 | 1.10 |
| P/B | 2.59 | 8.74 |
| Revenue growth | +9.80% | +6.80% |
| EPS growth | +12.10% | — |
| Gross margin % | 65.0 | 56.6 |
| Net margin % | 13.9 | -4.6 |
| ROE % | 10.4 | -36.4 |
| Debt / equity | 0.56 | 4.77 |
| FCF yield % | 4.7 | -3.1 |
| Dividend yield % | 2.81 | — |
| Beta | 0.14 | 1.11 |
| RSI (14) | 63.8 | 44.7 |
| Technical rating |